Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117439184 | 11743918 | 4 | F | 201508 | 20160811 | 20151116 | 20160818 | EXP | US-PFIZER INC-2015329828 | PFIZER | 61.00 | YR | M | Y | 0.00000 | 20160818 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117439184 | 11743918 | 1 | PS | LYRICA | PREGABALIN | 1 | Oral | UNK | 21446 | CAPSULE, HARD | |||||||||
| 117439184 | 11743918 | 2 | SS | LYRICA | PREGABALIN | 1 | Oral | 150 MG, 2X/DAY | 21446 | 150 | MG | CAPSULE, HARD | BID | ||||||
| 117439184 | 11743918 | 3 | SS | LYRICA | PREGABALIN | 1 | Oral | 150 MG, 2X/DAY | 21446 | 150 | MG | CAPSULE, HARD | BID | ||||||
| 117439184 | 11743918 | 4 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 81 MG, DAILY | 0 | 81 | MG | CHEWABLE TABLET | |||||||
| 117439184 | 11743918 | 5 | C | FLEXERIL | CYCLOBENZAPRINE HYDROCHLORIDE | 1 | 10 MG, 3X/DAY (AS NEEDED ) | 0 | 10 | MG | TABLET | TID | |||||||
| 117439184 | 11743918 | 6 | C | TIAZAC | DILTIAZEM HYDROCHLORIDE | 1 | Oral | 360 MG, DAILY | 0 | 360 | MG | CAPSULE | |||||||
| 117439184 | 11743918 | 7 | C | LODINE | ETODOLAC | 1 | Oral | 800 MG, DAILY | 0 | 800 | MG | TABLET | |||||||
| 117439184 | 11743918 | 8 | C | LASIX | FUROSEMIDE | 1 | Oral | 40 MG, 1X/DAY | 0 | 40 | MG | TABLET | QD | ||||||
| 117439184 | 11743918 | 9 | C | LOPID | GEMFIBROZIL | 1 | Oral | 600 MG, 2X/DAY | 0 | 600 | MG | TABLET | BID | ||||||
| 117439184 | 11743918 | 10 | C | PRINIVIL | LISINOPRIL | 1 | Oral | 40 MG, DAILY | 0 | 40 | MG | TABLET | |||||||
| 117439184 | 11743918 | 11 | C | ZESTRIL | LISINOPRIL | 1 | Oral | 40 MG, DAILY | 0 | 40 | MG | TABLET | |||||||
| 117439184 | 11743918 | 12 | C | GLUCOPHAGE XR | METFORMIN HYDROCHLORIDE | 1 | Oral | 500 MG, 2X/DAY | 0 | 500 | MG | TABLET | BID | ||||||
| 117439184 | 11743918 | 13 | C | NASONEX | MOMETASONE FUROATE | 1 | Nasal | 100 UG, DAILY (50 MCG/ACT NASAL SPRAY: ADMINISTER 2 SPRAYS INTO NOSTRIL(S) DAILY) | 0 | 100 | UG | NASAL SPRAY | |||||||
| 117439184 | 11743918 | 14 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | 20 MG, DAILY | 0 | 20 | MG | CAPSULE | |||||||
| 117439184 | 11743918 | 15 | C | PRAVACHOL | PRAVASTATIN SODIUM | 1 | Oral | 40 MG, 1X/DAY EVERY EVENING | 0 | 40 | MG | TABLET | QD | ||||||
| 117439184 | 11743918 | 16 | C | CIALIS | TADALAFIL | 1 | Oral | 20 MG, DAILY (AS NEEDED) | 0 | 20 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 117439184 | 11743918 | 1 | Diabetic neuropathy |
| 117439184 | 11743918 | 2 | Neuropathy peripheral |
| 117439184 | 11743918 | 3 | Congenital neuropathy |
| 117439184 | 11743918 | 5 | Muscle spasms |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 117439184 | 11743918 | OT |
| 117439184 | 11743918 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 117439184 | 11743918 | Impaired work ability | |
| 117439184 | 11743918 | Peripheral swelling |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 117439184 | 11743918 | 2 | 20151112 | 0 | ||
| 117439184 | 11743918 | 3 | 20160808 | 0 |